Skip to main content
. 2013 Mar 7;4(3):422–432. doi: 10.18632/oncotarget.917

Figure 2. The effect of the cytotoxic LHRH analog, AN-152 (AEZS-108), on the growth of xenotransplanted U-87 MG, human glioblastoma tumors.

Figure 2

The pooled standard errors of the groups: control: 313.9; D-Trp6-LHRH: 645.3; doxorubicin (DOX): 267.8, D-Trp6-LHRH + DOX: 308.9; AN-152: 172.1. Numbers in brackets are the number of successfully grafted tumors. Numbers at the end of each line represents the tumor doubling times. * = p < 0.05 vs. control for the repeated measure evaluation of tumor growth progression curves.